Surfactant therapy in neonates with respiratory failure due to haemorrhagic pulmonary oedema

被引:38
作者
Amizuka, T
Shimizu, H
Niida, Y
Ogawa, Y
机构
[1] Saitama Med Sch, Saitama Med Ctr, Dept Paediat, Kawagoe, Saitama 3508550, Japan
[2] Hokkaido Childrens Hosp & Med Ctr, Dept Paediat, Hokkaido, Japan
关键词
pulmonary haemorrhage; pulmonary oedema; pulmonary surfactant;
D O I
10.1007/s00431-003-1276-x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We studied the clinical and biochemical factors associated with surfactant dysfunction and factors affecting the responsiveness to exogenous surfactant among 27 neonates with haemorrhagic pulmonary oedema (HPE). HPE was defined as the presence of a large amount of blood-stained lung effluent and respiratory failure which was difficult to differentiate from respiratory distress syndrome. Among the neonates, 33% had very low birth weight, 96% were preterm, 70% were delivered by caesarean section, and 44% had delivery room intubation. The onset of HPE was at 1.5+/-0.1 h (mean +/- SEM) after birth. In 26 cases, surfactant was administered at 3.0+/-1.3 h after the onset of HPE. The concentrations of surfactant protein A (SP-A), disaturated phosphatidylcholine (DSPC), and albumin in the epithelial lining fluid were determined using the first lung effluent from the patients. The level of inhibitory activity against pulmonary surfactant in the effluent was determined in vitro. Surfactant inhibitory activity was associated with lower birth weight, earlier gestational age, delivery room intubation, earlier onset of HPE, and lower SP-A or DSPC concentration. A good response to exogenous surfactant, which was defined as ventilatory index <0.047 at 1 h after surfactant administration, was seen in 82% of cases, and was associated with lower serum albumin, lower birth weight, and earlier gestational age. Cases with higher DSPC concentration prior to surfactant administration and shorter interval between the onset of HPE and surfactant administration showed an immediate response to surfactant, followed by no increase in ventilatory index for 24 h after surfactant administration. Conclusion: exogenous surfactant appeared to be a useful adjunctive therapy for overcoming surfactant inhibition and normalising the respiratory status of infants with haemorraghic pulmonary oedema. Surfactant treatment for this indication awaits further investigations including a randomised controlled study.
引用
收藏
页码:697 / 702
页数:6
相关论文
共 20 条
[1]  
BOMSEL F, 1970, J RADIOL ELEC MED N, V51, P259
[2]   Surfactant proteins and stable microbubbles in tracheal aspirates of infants with respiratory distress syndrome: Relation to the degree of respiratory failure and response to exogenous surfactant [J].
Chida, S ;
Fujiwara, T ;
Konishi, M ;
Shimada, S ;
Takahashi, A .
EUROPEAN JOURNAL OF PEDIATRICS, 1997, 156 (02) :131-138
[3]   PULSATING BUBBLE TECHNIQUE FOR EVALUATING PULMONARY SURFACTANT [J].
ENHORNING, G .
JOURNAL OF APPLIED PHYSIOLOGY, 1977, 43 (02) :198-203
[4]  
FEDRICK J, 1971, BIOL NEONATE, V18, P243
[5]  
FUJIWARA T, 1990, PEDIATRICS, V86, P753
[6]  
GARLAND J, 1994, PEDIATRICS, V94, P719
[7]   SURFACTANT PROTEIN-A, PHOSPHATIDYLCHOLINE, AND SURFACTANT INHIBITORS IN EPITHELIAL LINING FLUID - CORRELATION WITH SURFACE-ACTIVITY, SEVERITY OF RESPIRATORY-DISTRESS SYNDROME, AND OUTCOME IN SMALL PREMATURE-INFANTS [J].
HALLMAN, M ;
MERRITT, TA ;
AKINO, T ;
BRY, K .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (06) :1376-1384
[8]   EXOGENOUS HUMAN SURFACTANT FOR TREATMENT OF SEVERE RESPIRATORY-DISTRESS SYNDROME - A RANDOMIZED PROSPECTIVE CLINICAL-TRIAL [J].
HALLMAN, M ;
MERRITT, TA ;
JARVENPAA, AL ;
BOYNTON, B ;
MANNINO, F ;
GLUCK, L ;
MOORE, T ;
EDWARDS, D .
JOURNAL OF PEDIATRICS, 1985, 106 (06) :963-969
[9]   EFFECTS OF HEMOGLOBIN AND CELL-MEMBRANE LIPIDS ON PULMONARY SURFACTANT ACTIVITY [J].
HOLM, BA ;
NOTTER, RH .
JOURNAL OF APPLIED PHYSIOLOGY, 1987, 63 (04) :1434-1442
[10]  
KUROKI Y, 1985, BIOCHIM BIOPHYS ACTA, V836, P201